PHARMACOLOGY OF RYANODINE AND SR CALCIUM RELEASE
PHARMACOLOGY OF RYANODINE AND SR CALCIUM RELEASE
批准号:
3339172
负责人:
JOHN L SUTKO
金额:
$23.09万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-07-01 至 1994-11-30
关键词:
Anura binding proteins calcium channel calcium flux cell membrane chemical structure function chemical synthesis chickens disease /disorder model electrophysiology laboratory rabbit laboratory rat membrane permeability muscle function muscle pharmacology physiology protein structure function ryanodine sarcoplasmic reticulum striated muscles
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goals of the experiments first, to establish the in vitro effects of
ryanodine and a series of structural analogs of ryanodine on the calcium
permeability and calcium binding properties of SR membranes isolated from
skeletal, cardiac and vascular smooth muscles. Second, we will determine
the physiological consequences of the actions of these compounds by
characterizing the changes they produce in the function of intact muscle
preparations. In preliminary studies we have found that two diterpine
ester analogs of ryanodine, designated A and B, each cause only one of the
effects of ryanodine. Therefore, these compounds may selectively increase
and decrease a SR membrane calcium permeability and perhaps activate and
inhibit the calcium release channel.
1. We will extract and purify the following compounds from Ryania wood:
Ryanodine, dehydroryanodine, and the diterpine esters designated A, B, C1,
C2 and D. In addition, ryanodine will be chemically modified to form
9-epiryanodine, isodehydroryanodine, anhydroryanodine, oxoryanodine,
ryanodol and pyrrole-2-carboxylic acid.
2. In a series of in vitro investigations we will establish and compare the
effects of ryanodine and its analogs on passive and active calcium fluxes
across, and calcium binding by, SR membranes isolated from skeletal,
cardiac and smooth muscles. We will also determine the effects of these
compounds on the conductance and activation characteristics of calcium
channels incorporated into lipid bilayers from membrane fractions found to
be affected by the alkaloids. Ineffective compounds will be tested for
their ability to antagonize the actions of those compounds found to act at
one of the sites affected by ryanodine. The structure-activity information
obtained from these studies will be used to identify the structural
features of the ryanodine molecule which are important for each activity.
3. We will determine the ability of each compound to alter the rate of
oxygen consumption, cytoplasmic calcium activity and the mechanical and
electrical functions of intact skeletal, cardiac and smooth muscles. We
will correlate the structure-activity relationships obtained in these in
situ studies with those determined in the preceding step in order to
establish the cause and effect relationships existing between the in vitro
changes in SR calcium movements and the alterations in intact muscle
function produced by these compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ryanodine Receptor Calcium Fluxes
-
批准号:7017075
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2004
-
负责人:JOHN L SUTKO
-
依托单位:
Ryanodine Receptor Calcium Fluxes
-
批准号:7185785
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2004
-
负责人:JOHN L SUTKO
-
依托单位:
Ryanodine Receptor Calcium Fluxes
-
批准号:6676281
-
项目类别:
-
资助金额:$35.13万
-
财政年份:2004
-
负责人:JOHN L SUTKO
-
依托单位:
Ryanodine Receptor Calcium Fluxes
-
批准号:6866368
-
项目类别:
-
资助金额:$35.13万
-
财政年份:2004
-
负责人:JOHN L SUTKO
-
依托单位:
RYANODINE RECEPTOR REGULATION
-
批准号:6375085
-
项目类别:
-
资助金额:$26.06万
-
财政年份:1999
-
负责人:JOHN L SUTKO
-
依托单位:
RYANODINE RECEPTOR REGULATION
-
批准号:6632640
-
项目类别:
-
资助金额:$27.07万
-
财政年份:1999
-
负责人:JOHN L SUTKO
-
依托单位:
RYANODINE RECEPTOR REGULATION
-
批准号:6511907
-
项目类别:
-
资助金额:$26.29万
-
财政年份:1999
-
负责人:JOHN L SUTKO
-
依托单位:
RYANODINE RECEPTOR REGULATION
-
批准号:2472277
-
项目类别:
-
资助金额:$29.67万
-
财政年份:1999
-
负责人:JOHN L SUTKO
-
依托单位:
RYANODINE RECEPTOR REGULATION
-
批准号:6171438
-
项目类别:
-
资助金额:$26.03万
-
财政年份:1999
-
负责人:JOHN L SUTKO
-
依托单位:
ACTIVATION OF CA++ RELEASE IN SKELETAL AND HEART MUSCLE
-
批准号:2750454
-
项目类别:
-
资助金额:$21.76万
-
财政年份:1996
-
负责人:JOHN L SUTKO
-
依托单位:
ACTIVATION OF CA++ RELEASE IN SKELETAL AND HEART MUSCLE
-
批准号:6043837
-
项目类别:
-
资助金额:$22.62万
-
财政年份:1996
-
负责人:JOHN L SUTKO
-
依托单位:
ACTIVATION OF CA++ RELEASE IN SKELETAL AND HEART MUSCLE
-
批准号:2231728
-
项目类别:
-
资助金额:$21.23万
-
财政年份:1996
-
负责人:JOHN L SUTKO
-
依托单位:
ACTIVATION OF CA++ RELEASE IN SKELETAL AND HEART MUSCLE
-
批准号:2460103
-
项目类别:
-
资助金额:$23.38万
-
财政年份:1996
-
负责人:JOHN L SUTKO
-
依托单位:
PHARMACOLOGY OF RYANODINE AND THE SR CA CHANNEL
-
批准号:3339170
-
项目类别:
-
资助金额:$10.6万
-
财政年份:1986
-
负责人:JOHN L SUTKO
-
依托单位:
PHARMACOLOGY OF RYANODINE AND THE SR CA CHANNEL
-
批准号:3339167
-
项目类别:
-
资助金额:$18.96万
-
财政年份:1986
-
负责人:JOHN L SUTKO
-
依托单位:
PHARMACOLOGY OF RYANODINE AND THE SR CA CHANNEL
-
批准号:3339169
-
项目类别:
-
资助金额:$12.94万
-
财政年份:1986
-
负责人:JOHN L SUTKO
-
依托单位:
CA TRANSPORT IN CARDIAC MEMBRANE VESICLES
-
批准号:3354970
-
项目类别:
-
资助金额:$3.73万
-
财政年份:1986
-
负责人:JOHN L SUTKO
-
依托单位:
PHARMACOLOGY OF RYANODINE AND SR CALCIUM RELEASE
-
批准号:2216152
-
项目类别:
-
资助金额:$25.1万
-
财政年份:1981
-
负责人:JOHN L SUTKO
-
依托单位:
CA TRANSPORT IN CARDIAC MEMBRANE VESICLES
-
批准号:3338720
-
项目类别:
-
资助金额:$4.4万
-
财政年份:1981
-
负责人:JOHN L SUTKO
-
依托单位:
PHARMACOLOGY OF RYANODINE AND SR CALCIUM RELEASE
-
批准号:3339171
-
项目类别:
-
资助金额:$23.35万
-
财政年份:1981
-
负责人:JOHN L SUTKO
-
依托单位:
海外基金